Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says

by admin | Feb 11, 2026 | Uncategorized

Spread the love

The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.

Written by Albert Pham, News Curator and Blogger

Trump’s July Financial Disclosure Reveals Major Microsoft and Amazon Stock Trades

Trump’s July financial disclosure shows 1,156 securities transactions, including major Microsoft and Amazon stock sales worth up to $25 million each.

S&P 500 analysis shows technical sell signals are flashing despite Nvidia earnings hype.

The launch, which could happen as soon as Friday, comes ahead of “an IPO that’s basing so much” on narrative and symbolism.